Fairview Capital Investment Management, LLC Bristol Myers Squibb CO Transaction History
Fairview Capital Investment Management, LLC
- $1.67 Billion
- Q1 2024
A detailed history of Fairview Capital Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fairview Capital Investment Management, LLC holds 5,000 shares of BMY stock, worth $199,950. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,000
Previous 5,000
-0.0%
Holding current value
$199,950
Previous $256,000
5.86%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,555Shares Held
1.49BCall Options Held
25.9MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$7.44 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$6.5 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$3.66 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$3.55 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$2.81 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $85B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...